(July 26, 2011)
On July 6th, C.R. Bard, Inc. (parent company to Davol Inc.) negotiated settlement terms with over 100 law firms around the U.S., totaling $184 million in close to 2,600 lawsuits!! With statistics like this, you must be asking yourself what they got themselves into to be in this much legal trouble.
It turns out that C.R. Bard has found dangerous medical complications with their Composix Kugel Mesh hernia patch. Patients using this patch have reported bowel perforation, sepsis, intestinal fistulas, and abdominal abscess formation.
On February 4th, Judge Lisi denied Davol and C.R. Bard a new trial in one case, as well as denying their request to exclude medical expert testimony, stating that it was “undoubtedly helpful in assisting the jury” to understand the facts.
This was the latest to come from the August 2010 ruling that awarded the same plaintiffs, Christopher and Laure Thorpe, $1.3 million in personal injury damages and $200,000 for loss of consortium. Both Davol and C.R. Bard were liable for failing to warn about the faulty hernia patch, as well as acting unreasonably in the design of the patch.
Because Davol and C.R. Bard were negligent in the design, they needed to find a safer alternative. If they could not do so, they needed to remove the produce from the market, yet they did not do so.
Although the manufacturers agreed to settle, this process will take months to finalize. Multiple ring break and ring buckle cases were scheduled for trial at the time of this resolution.
Please contact one of our attorneys if you are reporting any of the symptoms associated with these Composix Kugel Mesh hernia patches,
Contact us today – 1-800-246-4878.
